What is the catalog number for Cofilin/CFL1 Rabbit Polyclonal Antibody?

The catalog number for Cofilin/CFL1 Rabbit Polyclonal Antibody is orb315128.

What sizes are available for Cofilin/CFL1 Rabbit Polyclonal Antibody?

Cofilin/CFL1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Cofilin/CFL1 Rabbit Polyclonal Antibody in stock?

Cofilin/CFL1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Cofilin/CFL1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Cofilin-1; 18 kDa phosphoprotein; p18; Cofilin, non-muscle isoform; CFL1; CFL

UniProt

P23528

Reactivity

Human, Monkey, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human Cofilin, identical to the related mouse and rat sequences.

Target

Cofilin-1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cardiovascular Research, Musculoskeletal & Connective Tissue Research, Neuroscience, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human, Monkey, Mouse, Rat Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Mouse, Rat Immunocytochemistry/Immunofluorescence, 5 μg/ml, Human

Form

Lyophilized

Molecular Weight

19 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ICC, IF, IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.